Dermapharm Holding rises after 'solid' 9-month results

Dermapharm Holding SE

16/11/2022 08:52

** Shares of Dermapharm Holding  DMPG.DE  are up 2% after
the German dermatology drugmaker published its 9-month results
above expectations
    ** The company's 9-month consolidated revenue rose 9.6%, 
consolidated EBITDA was up 5.1%
    ** Jefferies says Dermapharm released a "solid" set of
9-month figures with a 1% beat on topline and 2% on adj. EBITDA
vs. consensus
    ** The stock is among top risers on the German small-caps
index  .SDAXI 
 (Reporting by Anastasiia Kozlova)
 ((Anastasiia.Kozlova@thomsonreuters.com))